share_log
Breakings ·  Dec 20 18:59

Novo-Nordisk A/S's stock price plummeted by 23%, marking the largest single-day decline in 22 years. This was due to the disappointing trial results of Novo-Nordisk A/S's weight loss drug CagriSema.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment